Photodynamic therapy of C6-implanted glioma cells in the rat brain employing second-generation photosensitizer talaporfin sodium

Photodiagnosis and Photodynamic Therapy

Volumn 5, Issue 3, 2008, Pages 198-209

  Namatame, Hiroaki ^a   Akimoto, Jiro ^a   Matsumura, Hiroyuki ^a   Haraoka, Jo ^a   Aizawa, Katsuo ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

C6 glioma cell line; Malignant glioma; Photodynamic therapy; Talaporfin sodium; Transplanted rat glioma model

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; TALAPORFIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN EDEMA; BRAIN SURGERY; BRAIN TISSUE; CANCER CELL CULTURE; CANCER STAGING; CANCER TRANSPLANTATION; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CRANIOTOMY; CYTOPLASM; DIODE LASER; FRONTAL LOBE; GLIOBLASTOMA; GLIOMA CELL; HISTOLOGY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEREOTACTIC PROCEDURE; TUMOR CELL; TUMOR NECROSIS; TUMOR VOLUME;

ANIMALS; BRAIN; CELL LINE, TUMOR; GLIOMA; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 56449128653     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2008.08.001     Document Type: Article

References (49)

1. Lacroix M., Abi-Said D., Fourney D.R., Gokaslan Z.L., Shi W., DeMonte F., et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95 (2001) 190-198
2. Sawaya R., Hammound M., Schoppa D., Hess K.R., Wu S.Z., Shi W.M., et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42 (1998) 1044-1056
3. Stummer W., Pichlmeier U., Meinel T., Wiestler O.D., Zanella F., and Reulen H.J. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 7 (2006) 392-401
4. Wilson C.B. Glioblastoma: the past, the present, and the future. Clin Neurosurg 38 (1992) 32-48
5. Stummer W., Novotny A., Stepp H., Goets C., Bise K., and Reulen H.J. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93 (2000) 1003-1013
6. Kostron H., Obwegeser A., and Jakober R. Photodynamic therapy in neurosurgery: a review. J Photochem Photobiol B 36 2 (1996) 157-168
7. Perria C., Capuzzo T., Cavagnaro C., Datti R., Francaviglia N., Rivano C., et al. Fast attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci 24 (1980) 119-129
8. Perria C., Carai M., Falzoi A., Orunesu G., Rocca A., Massareli G., et al. Photodynamic therapy of malignant brain tumors: clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications. Neurosurgery 23 (1988) 557-563
9. Nelson J.S., Roberts W.G., and Berns M.W. In vivo studies on the utilization of mono-l-aspartyl chlorine (NPe6) for photodynamic therapy. Cancer Res 47 (1987) 4681-4685
10. Nelson J.S., Liaw L.H., Orenstein A., Roberts W.G., and Berns M.W. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J Natl Cancer Inst 80 (1988) 1599-1605
11. Bogaards A., Varma A., Zhang K., Zach D., Bisland S.K., Moriyama E.H., et al. Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development. Photochem Photobiol Sci 4 (2005) 438-442
12. Hill J.S., Kahl S.B., Stylli S.S., Nakamura Y., Koo M.S., and Kaye A.H. Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer. Proc Natl Acad Sci 92 (1995) 12126-12130
13. Bisland S.K., Ligle A., Lin A., Runsnov R., and Wilson B.C. Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem Photobiol 80 (2004) 22-30
14. Ligle L., and Wilson B.C. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. J Clin Laser Med Surg 16 2 (1998) 81-91
15. Ligle L., Portnoy M., and Wilson B.C. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumor tissue. Br J Cancer 83 3 (2000) 1110-1117
16. Muller P.J., and Wilson B.C. Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. J Clin Laser Med Surg 4 (1996) 263-270
17. Muller P.J., and Wilson B.C. Photodynamic therapy of brain tumors-a work in progress. Lasers Surg Med 38 (2006) 384-389
18. Rosenthal M.A., Kavar B., Hill J.S., Morgan D.J., Nation R.L., Stylli S.S., et al. Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin. J Clin Oncol 19 2 (2001) 519-524
19. Stylli S.S., Kaye A.H., MacGregor L., Howes M., and Rajendra P. Photodynamic therapy of high grade glioma-long term survival. J Clin Neurosci 12 4 (2005) 389-398
20. Angell-Petersen E., Spetalen S., Madsen S.J., Sun C.-H., Peng Q., Carper S.W., et al. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. J Neurosurg 104 (2006) 109-117
21. Madsen S.J., Sun C.-H., Tromberg B.J., and Hirschberg H. Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids. J Neuro-Oncol 62 (2003) 243-250
22. Madsen S.J., Angell-Petersen E., Spetalen S., Carper S.W., Ziegler S.A., and Hirschberg H. Photodynamic therapy of newly implanted glioma cells in the rat brain. Lasers Surg Med 38 (2006) 540-548
23. Olzowy B., Hundt C.S., Stocker S., Bise K., Reulen H.J., and Stummer W. Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. J Neurosurg 97 (2002) 970-976
24. Eljamel M., Goodman C., and Moseley H. ALA and Photofrin fluorescence guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomized controlled trial. Lasers Med Sci 23 4 (2008) 361-367
25. Eljamel S. Photodynamic assisted surgical resection and treatment of malignant brain tumours; technique, technology and clinical application. Photodiag Photudyn Ther 1 (2004) 93-98
26. Kaye A.H., Morstyn G., and Brownbill D. Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma, a phase I/II study. J Neurosurg 67 (1987) 500-505
27. Kostron H., Fritsch E., and Grunert V. Photodynamic therapy of malignant brain tumors; a phase I/II trial. Br J Neurosurg 2 (1988) 241-248
28. Aizawa K., Okunaka T., Ohtani T., Kawabe H., Yasunaka Y., O'Hata S., et al. Localization of mono-l-aspartyl chlorine e6 (Npe6) in mouse tissue. Photochem Photobiol 46 5 (1987) 789-793
29. Matsumura H., Akimoto J., Haraoka J., and Aizawa K. Uptake and retention of novel photosensitizer mono-l-aspartyl chlorine e6 in experimental malignant glioma. Laser Med Sci 23 3 (2008) 237-245
30. Tsuchida T., Aizawa K., Konaka C., and Kato H. Interaction of bovine serum albumin with mono-l-asparthyl chlorine e6 by spectrophotometry. Lasers Life Sci. 5 3 (1993) 155-164
31. Ferrario A., Kessel D., and Gomer C.J. Metabolic properties and photosensitizing responsiveness of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res 52 (1992) 2890-2893
32. Gomer C.J., and Ferrario A. Tissue distribution and photosensitizing properties of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res 50 (1990) 3985-3990
33. Katsumi T., Aizawa K., Kuroiwa Y., Saito K., Kurata Y., Ii Yl., et al. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-l-aspartyl chlorine e6. Photochem Photobiol 64 (1996) 671-675
34. Kaneko T., Chiba H., Yasuda T., and Kusama K. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model. Oral Oncol 40 (2004) 787-792
35. Louis-Michel W.K.S., Wang K.K., and Zinsmeister A.R. Mono-l-aspartyl chlorine e6 (Npe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer 82 (1998) 421-427
36. Nakamura H., Suzuki Y., Takeichi M., Saito T., Takayama M., and Aizawa K. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-l-aspartyl chlorine e6 (NPe6) against uterine cervical carcinoma cell lines. Int J Gynecol Cancer 12 (2002) 177-186
37. Habeda K.M., Kamphorst W., Sterenborg H.J., and Wolbers J.G. Damage to tumor and brain by interstitial photodynamic therapy in the 9L rat tumor model comparing intravenous and intratumoral administration of the photosensitizer. Acta Neurochir (Wien) 140 (1998) 495-501
38. Roberts W.G., and Berns M.W. In vitro photosensitization. I. Cellular uptake and subcellular localization of mono-l-aspartyl chlorine e6, chloro-aluminium sulfonated phthalocyanine, and photofrin II. Lasers Surg Med 9 2 (1989) 90-101
39. Chen Q., Chopp M., Madigan L., Dreski M.O., and Hetzel F.W. Damage threshold of normal brain in photodynamic therapy. Photochem Photobiol 64 (1996) 163-167
40. Dereski M.O., Chopp M., Gracia J.H., and Hetzel F.W. Depth measurements and histopathological characterization of photodynamic therapy generated normal brain necrosis as a function of incident optical energy dose. Photochem Photobiol 54 (1991) 109-112
41. Yoshida Y., Dereski M.O., Garcia J.H., Hetzel F.W., and Chopp M. Neuronal injury after photoactivation of photofrin II. Am J Pathol 141 (1992) 989-997
42. Yoshida Y., Dereski M.O., Garcia J.H., Hetzel F.W., and Chopp M. Photoactivated photofrin II: astrocytic swelling precedes endothelial injury in rat brain. J Neuropath Exp Neurol 51 (1992) 91-100
43. Kessel D., Luo Y., Mathieu P., and Reiners Jr. J.J. Determinants of the apoptotic response to lysosomal photodamage. Photochem Photobiol 65 (2000) 410-415
44. Kessel D., Graca M., Vicente H., and Reiners Jr. J.J. Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg Med 38 (2006) 482-488
45. Roberts W.G., Shiau F.Y., Nelson J.S., Smith K.M., and Berns M.W. In vitro characterization of monoaspartyl chlorine e6 and diaspartyl chlorine e6 for photodynamic therapy. J Natl Cancer Inst 80 5 (1988) 330-336
46. Reiners J.J., Carso J.A., Matieu P., Chelladurai B., Yin X.M., and Kessel D. Release of cytochrome c and activation of procaspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ 9 (2002) 934-944
47. Stolka V., Turk B., Schendel S.L., Kim T.-H., Cirman T., Snipes S.J., et al. Lysosomal protease pathways to apoptosis: cleavage Bid, not pro-caspases, is the most likely route. J Chem 276 (2001) 3149-3157
48. Yamamoto Y., Shibuya H., Okunaka T., Aizawa K., and Kato H. Fibrin plugging as a cause of microcirculatory occlusion during photodynamic therapy. Lasers Med Sci 14 (1999) 129-135
49. Yuan F., Salehi H.A., Boucher Y., Vasthare U.S., Tuma R.F., and Jain R.K. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 54 (1994) 4564-4568